New Delhi (India), March 29: Under Rex Maughan, Forever Giving Foundation, Forever Living Products (India) did a successful camp with Thalassemics India at Nizamuddin, New Delhi.
Thalassemia is an inherited blood disorder that causes the body to produce less haemoglobin than usual. India is known as the capital of thalassemia. Patients with thalassemia need lifelong blood transfusions.
Given the nature of the problem, FLP India collaborated with Thalassemics India for the distribution of the medicines, including Iron Chelation therapy, an essential drug and blood leucocyte filters which are used while taking blood transfusions to remove white blood cells, or leucocytes, from the blood because the presence of white blood cells in the blood can increase the risk of certain complications, such as febrile nonhemolytic transfusion reactions (fever, chills, and nausea) and alloimmunization.
Mr. Harish Singla, CSM Forever Living Products (India) said, ‘The goal of this initiative was to create awareness and perspectives on safe blood transfusions in India, with a special emphasis on thalassemia patients.
As a responsible and caring brand, Forever Living Products India has been leading on the CSR front since the beginning, whether it’s contributing 2 million meals for ‘Rise Against Hunger’ or contributing 100 thousand USD to PM Care Fund. Recently, In Ahmedabad, a medical camp was organised where free medicines were distributed to the underprivileged, economically backward people and tribal women (expectant mothers and children below 7 years of age).’
Thalassaemia is an inherited autosomal recessive blood disorder that affects 2 million people in India. Around 1 00,000 children (thalassemic major) are in India. Of the total world thalassemics,10% are born in India every year. It is estimated that there are more than 45 million carriers of beta-thalassemia in India.
